Seres Therapeutics

Seres Therapeutics

Seres Therapeutics

SERES HEALTH designs and develops products that will improve the dignity for patients with stomas & ostomies
Founded
2010
Raised
$267.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$65,000,000
Venture capital (Series D) - 2015
Nestlé Health Science
Team Size
10+
Employees
$134,000,000 IPO
Xconomy

Bon Appetit: Seres And Its Microbiome Gut Treatment Notch $134M IPO

Health
$65,000,000 Venture capital (Series D)
prnewswire

Seres Health Announces $65 Million Investment from Nestle Health Science